RNAi Drug Delivery Market 2024-2028
Incremental Growth2024-2028 (US$bn)
$ 193.2
2024 Year-over-Year Growth
20.94%
CAGR (2024-2028)
27.16%
Report Coverage
Global
RNAi Drug Delivery Market Segmentation
Market Segmentation & Scope
Market Segment by Geographic Landscape
41%
of the growth will originate
from North America
Global Market Size 2018 - 2028 (US$ Bn)
Market is segmented by Technology into Nanoparticle drug delivery, Pulmonary drug delivery, Nucleic acid drug delivery, Aptamer drug delivery
The Nanoparticle drug delivery is expected to be largest growing segment during 2024-2028Largest Segment - Nanoparticle drug delivery
US$ 101.30 Bn
RNAi Drug Delivery Market by Technology into Nanoparticle drug delivery; 2018-2028 (US$ Bn)
Nanoparticle drug delivery Market Revenue and Forecast 2018-2028 (US$ Bn)Nanoparticle drug delivery
- Nanoparticle drug delivery Market Size and Forecast 2018 to 2028 (US$ Bn)
RNAi Drug Delivery Market by Technology into Pulmonary drug delivery; 2018-2028 (US$ Bn)
Pulmonary drug delivery Market Revenue and Forecast 2018-2028 (US$ Bn)Pulmonary drug delivery
- Pulmonary drug delivery Market Size and Forecast 2018 to 2028 (US$ Bn)
RNAi Drug Delivery Market by Technology into Nucleic acid drug delivery; 2018-2028 (US$ Bn)
Nucleic acid drug delivery Market Revenue and Forecast 2018-2028 (US$ Bn)Nucleic acid drug delivery
- Nucleic acid drug delivery Market Size and Forecast 2018 to 2028 (US$ Bn)
RNAi Drug Delivery Market by Technology into Aptamer drug delivery; 2018-2028 (US$ Bn)
Aptamer drug delivery Market Revenue and Forecast 2018-2028 (US$ Bn)Aptamer drug delivery
- Aptamer drug delivery Market Size and Forecast 2018 to 2028 (US$ Bn)
Market is segmented by Application into Infectious diseases, Oncology, Cardiology, Neurology, Others
The Infectious diseases is expected to be largest growing segment during 2024-2028Largest Segment - Infectious diseases
US$ 76.40 Bn
RNAi Drug Delivery Market Size by Segmentation, by Application (US$ Bn)
Application | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infectious diseases | 10.90 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Oncology | XX | 9.80 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Cardiology | XX | XX | 7.90 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Neurology | XX | XX | XX | 7.80 | 9.20 | XX | XX | XX | XX | XX | XX | XX |
Others | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
RNAi Drug Delivery Market by Application into Infectious diseases; 2018-2028 (US$ Bn)
Infectious diseases Market Revenue and Forecast 2018-2028 (US$ Bn)Infectious diseases
- Infectious diseases Market Size and Forecast 2018 to 2028 (US$ Bn)
RNAi Drug Delivery Market by Application into Oncology; 2018-2028 (US$ Bn)
Oncology Market Revenue and Forecast 2018-2028 (US$ Bn)Oncology
- Oncology Market Size and Forecast 2018 to 2028 (US$ Bn)
RNAi Drug Delivery Market by Application into Cardiology; 2018-2028 (US$ Bn)
Cardiology Market Revenue and Forecast 2018-2028 (US$ Bn)Cardiology
- Cardiology Market Size and Forecast 2018 to 2028 (US$ Bn)
RNAi Drug Delivery Market by Application into Neurology; 2018-2028 (US$ Bn)
Neurology Market Revenue and Forecast 2018-2028 (US$ Bn)Neurology
- Neurology Market Size and Forecast 2018 to 2028 (US$ Bn)
RNAi Drug Delivery Market by Application into Others; 2018-2028 (US$ Bn)
Others Market Revenue and Forecast 2018-2028 (US$ Bn)Others
- Others Market Size and Forecast 2018 to 2028 (US$ Bn)
Market is segmented by Geography into ROW, Total, North America, Europe, Asia
The North America is estimated to contribute 41% to the growth of global market during the forecast period 2024-2028.Largest Segment - North America
41%
Regional share of different regions, including North America, Europe, Asia, Rest of World (ROW)
Region | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROW | 4.30 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Total | XX | 42.60 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
North America | XX | XX | 22.50 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Europe | XX | XX | XX | 13.80 | 16.30 | XX | XX | XX | XX | XX | XX | XX |
Asia | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
RNAi Drug Delivery Market Size by Geography into ROW; 2018-2028 (US$ Bn)
ROW Market Revenue and Forecast 2018-2028 (US$ Bn)RNAi Drug Delivery Market Size by Geography into Total; 2018-2028 (US$ Bn)
Total Market Revenue and Forecast 2018-2028 (US$ Bn)RNAi Drug Delivery Market Size by Geography into North America; 2018-2028 (US$ Bn)
North America Market Revenue and Forecast 2018-2028 (US$ Bn)RNAi Drug Delivery Market Size by Country into Canada; 2018-2028 (US$ Bn)
Canada Market Revenue and Forecast 2018-2028 (US$ Bn)RNAi Drug Delivery Market Size by Country into US; 2018-2028 (US$ Bn)
US Market Revenue and Forecast 2018-2028 (US$ Bn)RNAi Drug Delivery Market Size by Geography into Europe; 2018-2028 (US$ Bn)
Europe Market Revenue and Forecast 2018-2028 (US$ Bn)RNAi Drug Delivery Market Size by Country into Germany; 2018-2028 (US$ Bn)
Germany Market Revenue and Forecast 2018-2028 (US$ Bn)RNAi Drug Delivery Market Size by Country into UK; 2018-2028 (US$ Bn)
UK Market Revenue and Forecast 2018-2028 (US$ Bn)RNAi Drug Delivery Market Size by Geography into Asia; 2018-2028 (US$ Bn)
Asia Market Revenue and Forecast 2018-2028 (US$ Bn)RNAi Drug Delivery Market Size by Country into China; 2018-2028 (US$ Bn)
China Market Revenue and Forecast 2018-2028 (US$ Bn)Major Companies
Market Companies
Name | Profile | Employees | Headquarters | Website | |
---|---|---|---|---|---|
Alnylam Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Arbutus Biopharma Corp. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Arrowhead Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Bayer AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Benitec Biopharma Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
BioNTech SE | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
CureVac AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
e therapeutics plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Novo Nordisk AS | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Phio Pharmaceuticals | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Silence Therapeutics plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Silenseed Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
siRNAgen Therapeutics Corp. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Sirnaomics Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Sylentis S.A. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Thermo Fisher Scientific Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
TransCode Therapeutics Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
RNAi Drug Delivery Market Scope
- By Technology
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Technology, 2017 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Technology, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022
- Absolute $ Opportunity Analysis By Technology, 2024 to 2028
- By Application
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Application, 2017 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Application, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Application, 2017 to 2022
- Absolute $ Opportunity Analysis By Application, 2024 to 2028
- By Region
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Region, 2017 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Region, 2024 to 2028
- North America Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By Technology
- By Application
- Europe Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By Technology
- By Application
- Asia Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By Technology
- By Application
- Rest of World (ROW) Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Technology
- By Application
Major Companies
Market companies
Name | Profile | Employees | Headquarters | Website | |
---|---|---|---|---|---|
Alnylam Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Arbutus Biopharma Corp. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Arrowhead Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Bayer AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Benitec Biopharma Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
BioNTech SE | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
CureVac AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
e therapeutics plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Novo Nordisk AS | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Phio Pharmaceuticals | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Silence Therapeutics plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Silenseed Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
siRNAgen Therapeutics Corp. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Sirnaomics Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Sylentis S.A. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Thermo Fisher Scientific Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
TransCode Therapeutics Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Subscribe to World-Class Market Intelligence
Basic Plan
Experience the best of reports & insights